Related Experiment Video
Updated: Dec 17, 2025

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
CMS Responds to COVID-19 Crisis by Revising Regulations
Abstract:
The Centers for Medicare & Medicaid Services (CMS) and other federal agencies are busy churning out regulations and guidance documents in response to the COVID-19 crisis. CMS now requires plans to waive cost sharing for COVID-19-related immunizations, testing, and treatment and suspend utilization review requirements related to drug-supply limits unless these limits are related to patient safety.
Related Concept Videos
Drug Regulation
Global Regulatory Systems
Standards of Care I
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Drug Control Governance: Regulatory Bodies and Their Impact
Responses to Drought and Flooding

